| Oxaliplatin combination therapy | 5-FU/FA alone | |
|---|---|---|
| Average survival gain – base case (years) | 9.0 | 1.7 |
| Average survival gain – high resection rate (years) | 9.0 | 1.7 |
| Average survival gain – 0.75 survival (years) | 7.3 | 1.7 |
| Average survival gain – benefits discounted (years) | 8.49 | 1.69 |
| Cost per life year gained – base case (£) | 11985 | |
| Cost per life year gained – high resection rate (£) | 5489 | |
| Cost per life year gained – 0.75 survival (£) | 15624 | |
| Cost per life year gained – benefits discounted (£) | 12867 |